| scholarly article | Q13442814 |
| P2093 | author name string | P Wallén | |
| M Rånby | |||
| B Norrman | |||
| P2860 | cites work | Enzymatic properties of the one- and two-chain form of tissue plasminogen activator | Q42260744 |
| Purification of urokinase by affinity chromatography | Q44314762 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 193-200 | |
| P577 | publication date | 1985-05-01 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition. | |
| P478 | volume | 149 |
| Q46201428 | A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators |
| Q33876789 | Adhesion formation after laparoscopic surgery: what do we know about the role of the peritoneal environment? |
| Q70889890 | Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase |
| Q38669149 | Biophysical Mechanisms Mediating Fibrin Fiber Lysis. |
| Q36889156 | Diabetes mellitus as a prothrombotic condition |
| Q74840143 | Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains |
| Q42132095 | Effect of sucralfate on aspirin induced mucosal injury and impaired haemostasis in humans |
| Q36710526 | Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation. |
| Q42045390 | Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator |
| Q71763084 | Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin |
| Q42857449 | Kinetic studies on the effect of heparin and fibrin on plasminogen activators |
| Q41287140 | Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments |
| Q42926925 | Pathophysiology and prevention of postoperative peritoneal adhesions |
| Q37424777 | Peritoneal adhesion prevention with a biodegradable and injectable N,O-carboxymethyl chitosan-aldehyde hyaluronic acid hydrogel in a rat repeated-injury model |
| Q46332546 | Plasmin degradation of fibrin coatings on synthetic polymer substrates |
| Q39420015 | Postoperative Abdominal Adhesions: Clinical Significance and Advances in Prevention and Management |
| Q71985164 | Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease |
| Q73632878 | Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice |
| Q42861714 | Structural requirements of position A alpha-157 in fibrinogen for the fibrin-induced rate enhancement of the activation of plasminogen by tissue-type plasminogen activator |
| Q73579089 | Studies of the t-PA-catalyzed Glu-plasminogen activation on different models of polymeric fibrin |
| Q35224556 | The Mechanism of Plasminogen Activation and the Variability of the Fibrin Effector during Tissue‐type Plasminogen Activator—mediated Fibrinolysis |
| Q42859038 | The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of α2-antiplasmin |
| Q37103972 | The plasminogen-plasmin system |
| Q35477781 | The plasminogen-plasmin system in malignancy |
| Q36384872 | Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon |
| Q38236911 | Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent |
Search more.